OMDA vs BTSG
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
OMDA · Omada Health$15.09 ▼ 20.37%
BTSG · BrightSpring Health Services$67.15 ▲ 1.96%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- OMDA -26.9%
- BTSG +100.0%
Head to head
| Metric | OMDA | BTSG |
|---|---|---|
| Price | $15.09 | $67.15 |
| Change today | ▼ 20.37% | ▲ 1.96% |
| Market cap | $935.52M | $13.36B |
| Return, 3 months | -39.6% | +9.3% |
| Return, year to date | -4.4% | +79.3% |
| Return, 1 year | -25.7% | +102.6% |
| P/E (TTM) | 28.4 | 36.1 |
| P/B | 3.4 | 6.1 |
| P/E percentile vs own 5y | 85th | 58th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +43.1% | +26.4% |
| Net profit growth (YoY) | +199.7% | +81.6% |
| Gross margin | 68.2% | 12.5% |
| Operating margin | -0.1% | 3.4% |
| Net margin | 1.4% | 2.7% |
| Return on equity | 1.8% | 20.5% |
| Analyst target vs. price | +86.2% | +18.0% |
| Analyst buy share | 90% | 100% |
| RSI (14) | 31 | 60 |
| 30-day volatility | 97.8% | 46.4% |
| Max drawdown, 1 year | -59.1% | -23.6% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- BTSG is the largest of the group by market value.
- BTSG has returned the most over the past year.
- OMDA carries the lowest trailing P/E.
- OMDA is growing revenue fastest.
- BTSG keeps the most profit per dollar of sales.
- BTSG has been the calmest stock over the last 30 days.